THE CORPORATE LIBRARY

Related Party Transactions and Outside Related Director Information

Mylan Laboratories Inc. (MYL)

6/27/2006 Proxy Information

During fiscal 2006, Coury Investment Advisors, Inc. (“CIA”), the principals of which are two brothers of Mr. Coury, the Company’s Vice Chairman and Chief Executive Officer, served as the broker in connection with several of the Company’s employee benefit programs. CIA received no remuneration from Mylan.

Milan Puskar was employed by Mylan Pharmaceuticals Inc. from 1961 to 1972 and served in various positions during this period, including Secretary -Treasurer and Executive Vice President.

Mr. Todd was employed by Mylan Laboratories Inc. from 1970 until his retirement in 1999. He served in various positions during this period including Senior Vice President from 1987 to 1999.

9/15/2005 Proxy Information

Mr. Puskar was employed by Mylan Pharmaceuticals Inc. from 1961 to 1972 and served in various positions during this period, including Secretary -Treasurer and Executive Vice President. From 1972 to 1975, Mr. Puskar served as Vice President and General Manager of the Cincinnati division of ICN Pharmaceuticals Inc. In 1976, he returned to Mylan as President of Mylan Laboratories, a position he held until March 2000. Mr. Puskar also served as Vice Chairman of Mylan Laboratories from 1980 to 1993, President from 1976 to 2000 and as Chairman and Chief Executive Officer from 1993 until 2002.

Effective as of April 1, 2005, the Company and Coury Investment Advisors, Inc. (“CIAI”), a corporation 100% owned by two brothers of Mr. Coury, the Company’s Vice Chairman and Chief Executive Officer, by mutual agreement, terminated a Consulting and Counseling Agreement between the parties. Pursuant to such Consulting and Counseling Agreement, CIAI had rendered advisory services during fiscal 2005, for a fee of $25,000 per calendar quarter

Mr. Todd was employed by Mylan Laboratories Inc. from 1970 until his retirement in 1999. He served in various positions during this period including Senior Vice President from 1987 to 1999. For Mylan Pharmaceuticals Inc., Mr. Todd served as Vice President of Quality Control from 1978 to 1987, Senior Vice President from 1987 to 1991 and President from 1991 to 1999. In June 2001, he resumed an active management role with Mylan as its interim President and Chief Operating Officer and served in this capacity until 2002.

7/29/2005 10-K Information

Effective as of April 1, 2005, the Company and Coury Investment Advisors, Inc. (“CIAI”), a corporation 100% owned by two brothers of Mr. Coury, the Company’s Vice Chairman and Chief Executive Officer, by mutual agreement, terminated a Consulting and Counseling Agreement between the parties. Pursuant to such Consulting and Counseling Agreement, CIAI had rendered investment advisory services during fiscal 2005, for a fee of $25,000 per calendar quarter.

6/28/2004 Proxy Information

During a portion of fiscal 2004, Mylan maintained approximately $10.0 million on deposit with Centra Bank, Inc., which represented approximately 4% of the Bank’s total deposits. Mr. Leech serves as Centra Bank’s Chief Executive Officer. As of March 31, 2004, Mylan had no deposits with Centra Bank.

During fiscal 2004, the Company retained the services of Coury Investment Advisors, Inc., a corporation 100% owned by two brothers of Mr. Coury. In accordance with a Consulting and Counseling Agreement between the parties, Coury Investment Advisors rendered investment advisory services and was paid $25,000 each calendar quarter. The agreement may be terminated by the Company on 90 days’ notice.

Also during fiscal 2004, Coury Financial Group, the principals of which are two brothers of Mr. Coury, served as the broker in connection with securing the Company’s dental insurance plan for employees. Coury Financial Group received no remuneration from Mylan.

From March 2003 until September 2003, the Company leased office space from Corporate Drive Associates, L.P. (“CDA, L.P.”), the general partner of which was Corporate Drive Associates, Inc. (“CDA, Inc.”), a company by which Mr. Piatt had previously been employed as president. Mylan paid rent during that period in the aggregate amount of approximately $131,000. In October 2003, a wholly-owned subsidiary of the Company purchased the building in which the office space was located for $15 million. In connection with the building acquisition, the subsidiary had an independent appraiser value the property. Mr. Piatt is no longer employed by, or otherwise affiliated with, CDA, L.P. or CDA, Inc., and both entities have been dissolved.

Mr. Puskar was employed by Mylan Pharmaceuticals Inc. from 1961 to 1972 and served in various positions during this period, including Secretary-Treasurer and Executive Vice President.

Mr. Todd was employed by Mylan Laboratories Inc., from 1970 until his retirement in 1999. He served in various positions during this period including Senior Vice President from 1987 to 1999. For Mylan Pharmaceuticals Inc., Mr. Todd served as Vice President-Quality Control from 1978 to 1987, Senior Vice President from 1987 to 1991 and President from 1991 to 1999. In June 2001, he resumed an active management role with Mylan as its interim President and Chief Operating Officer and served in this capacity until 2002.

6/23/2003 Proxy Information

During fiscal 2003, Mylan maintained certain deposits in Centra Bank, Inc. Mr. Leech serves as Centra Bank’s Chief Executive Officer. As of March 31, 2003, Mylan had approximately $10.0 million on deposit with Centra Bank, Inc., which represents approximately four percent (4%) of the Bank's total deposits.

Prior to Mr. Coury accepting his position as Chief Executive Officer in July 2002, a Consulting Agreement between Mylan Laboratories Inc. and Coury Consulting, L.P., a strategic advisory firm controlled by Mr. Coury, was terminated. Under that agreement, Coury Consulting, L.P. provided strategic advisory services to the Company. While the agreement was in effect during fiscal 2003, and prior to Mr. Coury’s becoming Chief Executive Officer, Coury Consulting, L.P. was paid $380,000.

In February 2003, Mr. Williams terminated an “of counsel” relationship he had during most of fiscal 2003 with the DKW Law Group, P.C., a law firm that has been providing legal services to the Company for over 15 years. During fiscal 2003, the fees paid to that firm for legal services rendered to the Company totaled $6,302,000.

Effective October 1, 2002, the Company retained the services of Coury Investment Advisors, Inc., a corporation 100% owned by two brothers of Mr. Coury. In accordance with a Consulting and Counseling Agreement between the parties, Coury Investment Advisors is rendering investment advisory services and is paid $25,000 each calendar quarter. The firm also has an opportunity to earn a bonus; however, no bonus was paid in fiscal 2003. The agreement may be terminated by the Company on 90 days’ notice to Coury Investment Advisors.